Mirapexin prolonged release formulation launched

A once daily formulation of pramipexole (Mirapexin Prolonged Release) has been launched for the treatment of idiopathic Parkinson's disease.

The new preparation is available in five strengths: 0.26mg, 0.52mg, 1.05mg, 2.1mg and 3.15mg.
Treatment with Mirapexin Prolonged Release should be initiated at 0.26mg daily, increasing to a maximum of 3.15mg per day as necessary.

View Mirapexin drug record

Further information: Boehringer

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

NICE recommends 'innovative' treatment for type I diabetes

NICE recommends 'innovative' treatment for type I diabetes

Dapagliflozin (Forxiga) has been approved for routine...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Elleste Duet, Elleste Solo, Diprosone and Livial.

Potentially addictive medicines 'being prescribed for years'

Potentially addictive medicines 'being prescribed for years'

Hundreds of thousands of people are receiving prescriptions...

Calcium and Vitamin D Supplements for Osteoporosis

Calcium and Vitamin D Supplements for Osteoporosis

Formulations, doses and costs of osteoporosis supplements.